Caring for Life – this is our value statement and what inspires the people of CSAM each and every day. Our diverse portfolio of software solutions enables healthcare providers to access relevant clinical information at the point of care, so they can provide the highest quality care to patients.
CSAM has established itself as a leading Nordic niche player in the specialised eHealth market, with a unique blend of best-in-class innovative technology, and outstanding human skills. We have ten offices in five countries, employing nearly 150 talented individuals.
Our leading product portfolio includes innovative niche solutions in connected healthcare, medical imaging, women and children’s health, emergency and acute care, medication management, and laboratory information management systems.
Our family of products comprises:
- the Nordics’ #1 blood management software (CSAM ProSang)
- the Nordics’ #1 oncology medication software (CSAM Cytodose)
- the Nordics’ #1 non-radiology medical imaging software (CSAM Picsara)
- the Nordics’ #1 maternity software (CSAM Partus)
- Norway’s #1 emergency and acute software solution (CSAM AMIS)
- and Sweden’s #1 ambulance software solution (CSAM Paratus)
Healthcare information without boundaries.
Enabling excellent healthcare by providing innovative niche software.
At CSAM, we are daring, different and disruptive.
Our people are what make us great, bringing empathy, enthusiasm and expertise to everything we do.
The company’s commercial headquarters are located in Oslo, Norway. CSAM also has local offices in Stockholm, Gothenburg, Karlstad, Helsinki, Oulu, Tampere, and Warwickshire, as well as a wholly owned software engineering subsidiary in Cebu, in the Philippines.
As a privately-owned eHealth company, we focus on our customers, using profits to strengthen our products and services, create a great place to work for our employees, and serve as a responsible business within the global community.
Backed by strong financial partners, CSAM aspires to achieve continued growth both organically and through selected mergers and acquisitions.